Cargando…

Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?

Detalles Bibliográficos
Autores principales:	Mutti, Luciano, Pentimalli, Francesca, Baglio, Giovanni, Maiorano, Patrizia, Saladino, Rita Emilena, Correale, Pierpaolo, Giordano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270396/ https://www.ncbi.nlm.nih.gov/pubmed/32574270 http://dx.doi.org/10.3389/fimmu.2020.01208

Ejemplares similares

HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy
por: Correale, Pierpaolo, et al.
Publicado: (2020)

Is There Already a Need of Reckoning on Cancer Immunotherapy?
por: Correale, Pierpaolo, et al.
Publicado: (2021)

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
por: Meirson, Tomer, et al.
Publicado: (2022)

Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
por: Pentimalli, Francesca, et al.
Publicado: (2023)

Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology
por: Meirson, Tomer, et al.
Publicado: (2022)

On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer
por: Correale, Pierpaolo, et al.
Publicado: (2020)

How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
por: Nardone, Valerio, et al.
Publicado: (2018)

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
por: Correale, Pierpaolo, et al.
Publicado: (2020)

PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach
por: Fameli, Antonella, et al.
Publicado: (2022)

Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis
por: Nardone, Valerio, et al.
Publicado: (2021)

B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover
por: Colucci, Manuela, et al.
Publicado: (2022)

Immune responses to Tilapia lake virus infection: what we know and what we don’t know
por: Kembou-Ringert, Japhette E., et al.
Publicado: (2023)

CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy
por: Nardone, Valerio, et al.
Publicado: (2021)

Tregs: Where We Are and What Comes Next?
por: Zhao, Hai, et al.
Publicado: (2017)

Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?
por: Feng, Min, et al.
Publicado: (2016)

What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the “Pink Swan”
por: Cardona, Pere-Joan
Publicado: (2017)

Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report
por: Botta, Cirino, et al.
Publicado: (2021)

Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade
por: Correale, Pierpaolo, et al.
Publicado: (2020)

The Novel Coronavirus Outbreak: What We Know and What We Don’t
Publicado: (2020)

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
por: Marshall, Michael J. E., et al.
Publicado: (2017)

Fungal Infection in the Brain: What We Learned from Intravital Imaging
por: Shi, Meiqing, et al.
Publicado: (2016)

The COVID-19 Cytokine Storm; What We Know So Far
por: Ragab, Dina, et al.
Publicado: (2020)

Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far
por: Prakash Babu, Senbagavalli, et al.
Publicado: (2019)

T peripheral helper cells in autoimmune diseases: What do we know?
por: Huang, Yao, et al.
Publicado: (2023)

Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade
por: Nardone, Valerio, et al.
Publicado: (2021)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
por: Rekvig, Ole Petter
Publicado: (2019)

Translating Tolerogenic Therapies to the Clinic – Where Do We Stand and What are the Barriers?
por: Cobbold, Stephen P., et al.
Publicado: (2012)

What Have We Learnt about BCG Vaccination in the Last 20 Years?
por: Dockrell, Hazel M., et al.
Publicado: (2017)

COVID-19 Mechanisms in the Human Body—What We Know So Far
por: Kumar, Ashutosh, et al.
Publicado: (2021)

2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2020)

Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
por: Gfeller, David, et al.
Publicado: (2018)

Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?
por: Jones, Katelyn, et al.
Publicado: (2020)

Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
por: Lv, Yue, et al.
Publicado: (2022)

What do we know about the function of SARS-CoV-2 proteins?
por: Justo Arevalo, Santiago, et al.
Publicado: (2023)

Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis
por: Correale, Jorge
Publicado: (2021)

Coronavirus disease 2019: What we know?
por: He, Feng, et al.
Publicado: (2020)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
por: Sun, Chuan-bin, et al.
Publicado: (2020)

Prebiotic Organic Chemistry of Formamide and the Origin of Life in Planetary Conditions: What We Know and What Is the Future
por: Bizzarri, Bruno Mattia, et al.
Publicado: (2021)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Correction to: 2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c60h24si7fdppuuvtkv34nhus7